Role and regulation of calcineurin in angiotensin II-stimulated cardiac myocyte hypertrophy of rats
Xu Song
Abstract
Xu Song
Abstract
AIM: To study the role and regulation of calcineurin(CaN) in angiotensin II(AngⅡ)-stimulated cardiacmyocyte hypertrophy of rats. METHODS: Using AngⅡ to induce the cultured cardiac myocyte hypertrophy of rats, and investigating the effect of CaN inhibitor on [ 3H]-leucine incorporation of AngⅡ-stimulated cardiomyocytes and the regulation of various factors on CaN activity in cardiomyocytes.RESULTS: AngⅡ can stimulate the CaN activity in cultured neonatal rat cardiomyocytes in a dose- and time-dependent manner. In cardiac myocytes incubated with 10, 100, 1000 nmol·L -1 of AngⅡ for 12h, the CaN activities increased respectively by 13%,57%( P0.05 ) and 228%( P 0.01) compared with that in non-stimulated cardiomyocytes. The CaN activities in AngⅡ-stimulated cardiomyocytes were significantly inhibited by losartan(50 μmol·L -1 ), H 7(50 μmol·L -1 )and Fura-2/AM(4 μmol·L -1 ),while no effect was observed with PD98059(50 μmol·L -1 ). The [ 3H]-leucine incorporation in AngⅡ-stimulated cardiomyocytes increased by 46%( P 0.01) compared with that in control group, which was dramatically inhibited by cyclosporin A(0.5~5 μg/mL). CONCLUSIONS: Calcineurin, a Ca 2+ /calmodulin-dependent protein phosphatase, may play an important role in AngⅡ-induced cardiac myocyte hypertrophy. The activation of CaN may dependent on the sustained increases of [Ca 2+ ]i and be regulated by some protein kinases (such as PKC,etc.).
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To study the role and regulation of calcineurin(CaN) in angiotensin II(AngⅡ)-stimulated cardiacmyocyte hypertrophy of rats. METHODS: Using AngⅡ to induce the cultured cardiac myocyte hypertrophy of rats, and investigating the effect of CaN inhibitor on [ 3H]-leucine incorporation of AngⅡ-stimulated cardiomyocytes and the regulation of various factors on CaN activity in cardiomyocytes.RESULTS: AngⅡ can stimulate the CaN activity in cultured neonatal rat cardiomyocytes in a dose- and time-dependent manner. In cardiac myocytes incubated with 10, 100, 1000 nmol·L -1 of AngⅡ for 12h, the CaN activities increased respectively by 13%,57%( P0.05 ) and 228%( P 0.01) compared with that in non-stimulated cardiomyocytes. The CaN activities in AngⅡ-stimulated cardiomyocytes were significantly inhibited by losartan(50 μmol·L -1 ), H 7(50 μmol·L -1 )and Fura-2/AM(4 μmol·L -1 ),while no effect was observed with PD98059(50 μmol·L -1 ). The [ 3H]-leucine incorporation in AngⅡ-stimulated cardiomyocytes increased by 46%( P 0.01) compared with that in control group, which was dramatically inhibited by cyclosporin A(0.5~5 μg/mL). CONCLUSIONS: Calcineurin, a Ca 2+ /calmodulin-dependent protein phosphatase, may play an important role in AngⅡ-induced cardiac myocyte hypertrophy. The activation of CaN may dependent on the sustained increases of [Ca 2+ ]i and be regulated by some protein kinases (such as PKC,etc.).
Key concepts: Calcineurin, Internal medicine, Myocyte, Endocrinology, Angiotensin II, Losartan, Muscle hypertrophy, Phosphatase